Question: The joint cost of blocking NGF, dose by dose, on a target whose receptor interface is solved
Adjudicated joint safety events on an anti-NGF antibody, arm by arm, with denominators
Collecting findings
0/2 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected